Baicalein and Baicalin Inhibit SARS-CoV-2 RNA-Dependent-RNA Polymerase
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Baicalein and Baicalin Inhibit SARS-CoV-2 RNA-Dependent-RNA Polymerase
Authors
Keywords
-
Journal
Microorganisms
Volume 9, Issue 5, Pages 893
Publisher
MDPI AG
Online
2021-04-22
DOI
10.3390/microorganisms9050893
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Coronavirus disease 2019 (COVID-19): current status and future perspectives
- (2020) Heng Li et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
- (2020) Calvin J. Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structure of replicating SARS-CoV-2 polymerase
- (2020) Hauke S. Hillen et al. NATURE
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
- (2020) David E. Gordon et al. NATURE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure of the RNA-dependent RNA polymerase from COVID-19 virus
- (2020) Yan Gao et al. SCIENCE
- Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
- (2020) Wanchao Yin et al. SCIENCE
- Toward Structurally Novel and Metabolically Stable HIV-1 Capsid-Targeting Small Molecules
- (2020) Sanjeev Kumar V. Vernekar et al. Viruses-Basel
- Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients
- (2020) Hai-xia Su et al. ACTA PHARMACOLOGICA SINICA
- Chemical profiling of HIV-1 capsid-targeting antiviral PF74
- (2020) Lei Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Potential Treatment of Chinese and Western Medicine Targeting Nsp14 of SARS-CoV-2
- (2020) Chao Liu et al. Journal of Pharmaceutical Analysis
- The comprehensive study on the therapeutic effects of baicalein for the treatment of COVID-19 in vivo and in vitro
- (2020) Junke Song et al. BIOCHEMICAL PHARMACOLOGY
- Remdesivir Strongly Binds to Both RNA-Dependent RNA Polymerase and Main Protease of SARS-CoV-2: Evidence from Molecular Simulations
- (2020) Hoang Linh Nguyen et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection
- (2018) Adrian Oo et al. ANTIVIRAL RESEARCH
- Baicalein and baicalin as Zika virus inhibitors
- (2018) Adrian Oo et al. ARCHIVES OF VIROLOGY
- Antiviral activity of selected flavonoids against Chikungunya virus
- (2016) Rafidah Lani et al. ANTIVIRAL RESEARCH
- Scutellaria baicalensis , the golden herb from the garden of Chinese medicinal plants
- (2016) Qing Zhao et al. Science Bulletin
- Discovery of an essential nucleotidylating activity associated with a newly delineated conserved domain in the RNA polymerase-containing protein of all nidoviruses
- (2015) Kathleen C. Lehmann et al. NUCLEIC ACIDS RESEARCH
- Baicalin, a metabolite of baicalein with antiviral activity against dengue virus
- (2014) Ehsan Moghaddam et al. Scientific Reports
- Novel Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Entry That Act by Three Distinct Mechanisms
- (2013) A. O. Adedeji et al. JOURNAL OF VIROLOGY
- Novel antiviral activity of baicalein against dengue virus
- (2012) Keivan Zandi et al. BMC Complementary and Alternative Medicine
- Evaluating the 3C-like protease activity of SARS-Coronavirus: Recommendations for standardized assays for drug discovery
- (2007) Valerie Grum-Tokars et al. VIRUS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation